RemeGen (09995.HK) Reports January 2026 Share Capital Changes

Bulletin Express02-25

RemeGen Co., Ltd. released a monthly update on its share capital for the period ended 31 January 2026. The authorized share capital for H shares remained at 208.58 million shares, while authorized A shares increased from 355.13 million shares to 355.90 million shares. Overall, the total authorized capital reached 564.48 million RMB.

No changes were recorded in the issued H shares, which stayed at 208.58 million shares with no treasury shares. For A shares, the issued portion rose by 0.57 million shares to 355.70 million shares, and treasury shares stood at 0.19 million shares at the end of the month.

The company attributed part of the changes to its A share incentive schemes announced previously. The relevant restricted shares were granted and lapsed according to their respective terms. The announced repurchase of certain A shares for the employee equity incentive program during January 2026 contributed to an increase in treasury shares. The public float requirement for H shares remained in compliance, with the listed H shares meeting the applicable threshold of 5%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197540587?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-25 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197540587","market":"us","top_or_hot":-1,"title":"RemeGen (09995.HK) Reports January 2026 Share Capital Changes","media":"Bulletin Express","content":"<p>RemeGen Co., Ltd. released a monthly update on its share capital for the period ended 31 January 2026. The authorized share capital for H shares remained at 208.58 million shares, while authorized A shares increased from 355.13 million shares to 355.90 million shares. Overall, the total authorized capital reached 564.48 million RMB.</p>\n<p>No changes were recorded in the issued H shares, which stayed at 208.58 million shares with no treasury shares. For A shares, the issued portion rose by 0.57 million shares to 355.70 million shares, and treasury shares stood at 0.19 million shares at the end of the month.</p>\n<p>The company attributed part of the changes to its A share incentive schemes announced previously. The relevant restricted shares were granted and lapsed according to their respective terms. The announced repurchase of certain A shares for the employee equity incentive program during January 2026 contributed to an increase in treasury shares. The public float requirement for H shares remained in compliance, with the listed H shares meeting the applicable threshold of 5%.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RemeGen (09995.HK) Reports January 2026 Share Capital Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRemeGen (09995.HK) Reports January 2026 Share Capital Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-25 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>RemeGen Co., Ltd. released a monthly update on its share capital for the period ended 31 January 2026. The authorized share capital for H shares remained at 208.58 million shares, while authorized A shares increased from 355.13 million shares to 355.90 million shares. Overall, the total authorized capital reached 564.48 million RMB.</p>\n<p>No changes were recorded in the issued H shares, which stayed at 208.58 million shares with no treasury shares. For A shares, the issued portion rose by 0.57 million shares to 355.70 million shares, and treasury shares stood at 0.19 million shares at the end of the month.</p>\n<p>The company attributed part of the changes to its A share incentive schemes announced previously. The relevant restricted shares were granted and lapsed according to their respective terms. The announced repurchase of certain A shares for the employee equity incentive program during January 2026 contributed to an increase in treasury shares. The public float requirement for H shares remained in compliance, with the listed H shares meeting the applicable threshold of 5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09995","symbol_name":"荣昌生物","start_time":0,"source_url":"","article_id":"1197540587","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197540587","pubTimestamp":1772008999,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"RemeGen Co., Ltd. released a monthly update on its share capital for the period ended 31 January 2026. The authorized share capital for H shares remained at 208.58 million shares, while authorized A...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09995":"荣昌生物"},"translate_title":"RemeGen(09995.HK)公布2026年1月股本变动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09995":1},"content_text":"RemeGen Co., Ltd. released a monthly update on its share capital for the period ended 31 January 2026. The authorized share capital for H shares remained at 208.58 million shares, while authorized A shares increased from 355.13 million shares to 355.90 million shares. Overall, the total authorized capital reached 564.48 million RMB.\nNo changes were recorded in the issued H shares, which stayed at 208.58 million shares with no treasury shares. For A shares, the issued portion rose by 0.57 million shares to 355.70 million shares, and treasury shares stood at 0.19 million shares at the end of the month.\nThe company attributed part of the changes to its A share incentive schemes announced previously. The relevant restricted shares were granted and lapsed according to their respective terms. The announced repurchase of certain A shares for the employee equity incentive program during January 2026 contributed to an increase in treasury shares. The public float requirement for H shares remained in compliance, with the listed H shares meeting the applicable threshold of 5%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197540587","isCrawlerRequest":true}